{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T09:26:23Z","timestamp":1748251583302,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.urolonc.2024.08.007","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T05:22:06Z","timestamp":1725945726000},"page":"65.e9-65.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: Real-life data from an Academic Center"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-4607","authenticated-orcid":false,"given":"Bar\u0131\u015f","family":"Esen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengi","family":"G\u00fcrses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mert","family":"Sekmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakup","family":"Kordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat Can","family":"Kiremit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Vural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tar\u0131k","family":"Esen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.08.007_bib0001","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.eururo.2019.09.020","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for deferred treatment with curative intent for localised prostate cancer from an International Collaborative Study (DETECTIVE Study)","volume":"76","author":"Lam","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0002","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1002\/cncr.34355","article-title":"Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions","volume":"128","author":"Fang","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0003","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/bco2.235","article-title":"Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging","volume":"4","author":"de Almeida","year":"2023","journal-title":"BJUI Compass"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0004","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.urology.2018.12.010","article-title":"Magnetic resonance imaging-defined prostate-specific antigen density significantly improves the risk prediction for clinically significant prostate cancer on biopsy","volume":"126","author":"Bhat","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0006","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system Version 2.1: 2019 update of prostate imaging reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0007","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41391-021-00417-1","article-title":"Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level","volume":"25","author":"Oerther","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging - reporting and Data System: 2015, Version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0009","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7-10 prostate cancer in biopsy-naive men","volume":"2","author":"Boesen","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0012","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.euo.2019.08.008","article-title":"Prebiopsy IMPROD biparametric magnetic resonance imaging combined with prostate-specific antigen density in the diagnosis of prostate cancer: an external validation study","volume":"3","author":"Knaapila","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0013","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.euo.2019.08.015","article-title":"Avoiding unnecessary magnetic resonance imaging (MRI) and Biopsies: negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and risk calculators","volume":"3","author":"Falagario","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0014","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.urology.2016.10.040","article-title":"Determination of the role of negative magnetic resonance imaging of the prostate in clinical practice: is biopsy still necessary?","volume":"102","author":"Wang","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/bju.14853","article-title":"Multiparametric magnetic resonance imaging and follow-up to avoid prostate biopsy in 4259 men","volume":"124","author":"Venderink","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0016","doi-asserted-by":"crossref","first-page":"e08325","DOI":"10.1016\/j.heliyon.2021.e08325","article-title":"Outcome of 5-year follow-up in men with negative findings on initial biparametric MRI","volume":"7","author":"Kortenbach","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0017","first-page":"13","article-title":"Intraobserver and interobserver agreement between six radiologists describing mpMRI features of prostate cancer using a PI-RADS 2.1 structured reporting scheme","author":"Jozwiak","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0018","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20201434","article-title":"Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer","volume":"95","author":"Urase","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.urology.2019.01.035","article-title":"The accuracy of prostate magnetic resonance imaging interpretation: impact of the individual radiologist and clinical factors","volume":"127","author":"Pickersgill","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.euf.2018.10.008","article-title":"Accuracy and variability of prostate multiparametric magnetic resonance imaging interpretation using the prostate imaging reporting and data system: a blinded comparison of radiologists","volume":"6","author":"Pickersgill","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0021","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00261-019-01934-3","article-title":"Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI)","volume":"44","author":"Gatti","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.prnil.2022.07.001","article-title":"Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes","volume":"10","author":"Hong","year":"2022","journal-title":"Prostate Int"},{"key":"10.1016\/j.urolonc.2024.08.007_bib0023","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2214\/AJR.18.20536","article-title":"Interreader variability of prostate imaging reporting and Data System Version 2 in detecting and assessing prostate cancer lesions at prostate MRI","volume":"212","author":"Greer","year":"2019","journal-title":"AJR Am J Roentgenol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924005787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:15:47Z","timestamp":1732706147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924005787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1078143924005787"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.08.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of PIRADS-2 lesions on serial multiparametric magnetic resonance imaging: Real-life data from an Academic Center","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}